9,10-dimethyl-1,2-benzanthracene has been researched along with Severe Combined Immunodeficiency in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atillasoy, ES; Elder, DE; Elenitsas, R; Herlyn, M; Montone, KT; Nesbit, M; Sauter, E; Seykora, JT; Soballe, PW | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Severe Combined Immunodeficiency
Article | Year |
---|---|
UVB induces atypical melanocytic lesions and melanoma in human skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Division; DNA, Neoplasm; Humans; Hyperplasia; In Situ Hybridization; Infant, Newborn; Male; Melanocytes; Melanoma; Mice; Mice, Knockout; Mice, SCID; Neoplasms, Radiation-Induced; Severe Combined Immunodeficiency; Skin; Skin Neoplasms; Skin Transplantation; Transplantation, Heterologous; Ultraviolet Rays | 1998 |